Watson Pharmaceuticals buys back $300 million shares

By Jennifer Chiou

New York, Sept. 13 - Watson Pharmaceuticals, Inc. said it completed its $300 million share repurchase program, buying back 9.4 million shares.

Under the program, announced in February, the company could buy back $300 million of its shares during a one-year period.

Based in Corona, Calif., Watson is a specialty pharmaceutical company that develops and distributes brand name and generic pharmaceutical products. The company's stock closed at $35.26 on Monday.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.